About AKASA
AKASA is the preeminent provider of generative AI solutions for the healthcare revenue cycle. The company has raised more than $205M in funding from investors such as Andreessen Horowitz, BOND, and Costanoa Ventures. 
Named one of the fastest-growing GenAI startups to watch by AIM Research, we’re solving the biggest challenges in the financial infrastructure of healthcare. Transaction volume through the AKASA Platform has grown consistently, with a ~2.5x year-over-year increase in the last year. The AKASA customer base represents more than $90B in net patient revenue and includes the most innovative health systems in the country, like Stanford and Johns Hopkins.    
Our founding team includes Silicon Valley leaders who have founded or been founding team members of multiple companies with successful exits. Our CEO was ranked among the “Top 50 Healthcare Technology CEOs” by the Healthcare Technology Report. We have been recognized as one of “America’s Best Startup Employers” by Forbes, “Most Innovative Digital Health ...